1. Home
  2. CNTB vs MIST Comparison

CNTB vs MIST Comparison

Compare CNTB & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • MIST
  • Stock Information
  • Founded
  • CNTB 2012
  • MIST 2003
  • Country
  • CNTB United States
  • MIST Canada
  • Employees
  • CNTB N/A
  • MIST N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • MIST Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNTB Health Care
  • MIST Health Care
  • Exchange
  • CNTB Nasdaq
  • MIST Nasdaq
  • Market Cap
  • CNTB 44.2M
  • MIST 89.8M
  • IPO Year
  • CNTB 2021
  • MIST N/A
  • Fundamental
  • Price
  • CNTB N/A
  • MIST $1.94
  • Analyst Decision
  • CNTB Strong Buy
  • MIST Strong Buy
  • Analyst Count
  • CNTB 2
  • MIST 2
  • Target Price
  • CNTB $7.50
  • MIST $7.50
  • AVG Volume (30 Days)
  • CNTB 103.1K
  • MIST 566.2K
  • Earning Date
  • CNTB 05-15-2025
  • MIST 08-07-2025
  • Dividend Yield
  • CNTB N/A
  • MIST N/A
  • EPS Growth
  • CNTB N/A
  • MIST N/A
  • EPS
  • CNTB N/A
  • MIST N/A
  • Revenue
  • CNTB $26,033,000.00
  • MIST N/A
  • Revenue This Year
  • CNTB N/A
  • MIST N/A
  • Revenue Next Year
  • CNTB N/A
  • MIST N/A
  • P/E Ratio
  • CNTB N/A
  • MIST N/A
  • Revenue Growth
  • CNTB N/A
  • MIST N/A
  • 52 Week Low
  • CNTB $0.51
  • MIST $0.63
  • 52 Week High
  • CNTB $1.60
  • MIST $2.75
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 72.64
  • MIST 65.73
  • Support Level
  • CNTB $1.02
  • MIST $1.86
  • Resistance Level
  • CNTB $1.07
  • MIST $1.97
  • Average True Range (ATR)
  • CNTB 0.09
  • MIST 0.10
  • MACD
  • CNTB 0.01
  • MIST 0.00
  • Stochastic Oscillator
  • CNTB 91.19
  • MIST 80.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: